- Home
- CDXS vs OXSQ Comparison
CDXS vs OXSQ Comparison
Compare CDXS & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CDXS | OXSQ |
|---|---|---|
| Founded | 2002 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Blank Checks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.8M | 151.9M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | CDXS | OXSQ |
|---|---|---|
| Price | $1.83 | $1.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 805.0K | ★ 1.2M |
| Earning Date | 02-26-2026 | 02-27-2026 |
| Dividend Yield | N/A | ★ 22.83% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $52,932,000.00 | $40,142,565.00 |
| Revenue This Year | $15.64 | N/A |
| Revenue Next Year | $5.23 | $2.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.52 | $1.56 |
| 52 Week High | $5.43 | $2.87 |
Technical Indicators
Market Signals| Indicator | CDXS | OXSQ |
|---|---|---|
| Relative Strength Index (RSI) | 58.06 | 53.33 |
| Support Level | $1.61 | $1.82 |
| Resistance Level | $1.74 | $1.98 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 92.59 | 46.81 |
Price Performance
Historical ComparisonAbout CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.